ZIOPHARM Oncology, Inc

ZIOPHARM Oncology, Inc., a biopharmaceutical company, focuses on the development and commercialization of in-licensed cancer drugs in North America. The companys products under various clinical programs include Palifosfamide for the treatment of sarcoma, testicular cancer, head and neck cancer, lymphomas, and other solid tumors; Darinaparsin, an anti-mitochondrial compound for the treatment of acute promyelocytic leukemia, a precancerous condition; and Indibulin, a novel orally available small molecular-weight inhibitor of tubulin polymerization, as well as develops novel DNA-based biotherapeutics.

Browse Reports
Tel / Fax
T. + 82-2-515-4235
F. + 82-2-514-4399
Email
web@clubritz.com
Facebook
www.facebook.com
Address
서울 강남구 영동대로129길 10 진성빌딩 2F 경기고등학교정문옆길 ( 구. 삼성동 58-6 2F )

Your map will be shown in here.

YOUR NAME *
YOUR EMAIL *
YOUR PHONE *
PASSWORD *
MESSAGE